UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 36.

Klein, H J; Schanz, U; Hivelin, M; Waldner, M; Koljonen, V; Guggenheim, M; Giovanoli, P; Gorantla, V S; Fehr, T; Plock, J A (2016). Sensitization and desensitization of burn patients as potential candidates for vascularized composite allotransplantation. Burns, 42(2):246-257.

Matter-Walstra, K W; Greiner, M; Cusini, A; Schiesser, M; Ledergerber, B; Fehr, T; Mueller, N J (2015). Stringent adherence to a cytomegalovirus-prevention protocol is associated with reduced overall costs in the first 6 months after kidney transplantation. Transplant Infectious Disease, 17(3):342-349.

Cippà, P E; Gabriel, S S; Kraus, A K; Chen, J; Wekerle, T; Guimezanes, A; Wüthrich, R P; Fehr, T (2014). Bcl-2 inhibition to overcome memory cell barriers in transplantation. American Journal of Transplantation, 14(2):333-342.

Haspot, F; Li, H W; Lucas, C L; Fehr, T; Beyaz, S; Sykes, M (2014). Allospecific rejection of MHC class I-deficient bone marrow by CD8 T cells. American Journal of Transplantation, 14(1):49-58.

Raess, M; Frohlich, G; Roos, Malgorzata; Rusi, B; Wilhelm, M J; Noll, G; Ruschitzka, F; Fehr, T; Enseleit, F (2013). Donor-specific anti-HLA antibodies detected by Luminex: predictive for short-term but not long-term survival after heart transplantation. Transplant International, 26(11):1097-1107.

Schleich, A; Fehr, T; Gaspert, A; Wuthrich, R P; Mohebbi, N (2013). Unexpected deterioration of graft function after combined kidney and pancreas transplantation. Clinical Kidney Journal, 6(2):228-230.

Varga, Z; Gaspert, A; Behnke, S; von Teichman, A; Fritzsche, F R; Fehr, T (2012). Tubular and endothelial chimerism in renal allografts using fluorescence and chromogenic in situ hybridization (FISH, CISH) technology. Pathology international, 62(4):254-263.

Greiner, M; Cusini, A; Ruesch, M; Schiesser, M; Ledergerber, B; Fehr, T; Mueller, N J (2012). A stringent preemptive protocol reduces cytomegalovirus disease in the first 6 months after kidney transplantation. Infection, 40(6):669-675.

Sullivan, M; Rybicki, L A; Winter, A; Hoffmann, M M; Reiermann, S; Linke, H; Arbeiter, K; Patzer, L; Budde, K; Hoppe, B; Zeier, M; Lhotta, K; Bock, A; Wiech, T; Gaspert, A; Fehr, T; Woznowski, M; Berisha, G; Malinoc, A; Goek, O N; Eng, C; Neumann, H P H (2011). Age-related penetrance of hereditary atypical hemolytic uremic syndrome. Annals of Human Genetics, 75(6):639-647.

Fehr, T; Cohen, C D (2011). Predicting an allograft's fate. Kidney International, 80(12):1254-1255.

Fritzsche, F R; Pianca, S; Gaspert, A; Varga, Z; Wang, L; Farrell, M P; Chen, X B; Hirsch, H H; Springer, E; Fehr, T; Myles, J; Tubbs, R; Moch, H (2011). Silver-enhanced in situ hybridization for detection of polyomavirus DNA in patients with BK virus nephropathy. Diagnostic Molecular Pathology, 20(2):105-110.

Lehmann, K; Müller, M K; Schiesser, M; Wildi, S; Fehr, T; Wüthrich, R P; Clavien, P A; Weber, M (2011). Treatment of ureteral complications after kidney transplantation with native ureteropyelostomy reduces the risk of pyelonephritis. Clinical Transplantation, 25(2):201-206.

Neusser, M A; Kraus, A K; Regele, H; Cohen, C D; Fehr, T; Kerjaschki, D; Wüthrich, R P; Penfold, M E; Schall, T; Segerer, S (2010). The chemokine receptor CXCR7 is expressed on lymphatic endothelial cells during renal allograft rejection. Kidney International, 77(9):801-808.

Gianella, S; Haeberli, L; Joos, B; Ledergerber, B; Wüthrich, R P; Weber, R; Kuster, H; Hauser, P M; Fehr, T; Mueller, N J (2010). Molecular evidence of interhuman transmission in an outbreak of Pneumocystis jirovecii pneumonia among renal transplant recipients. Transplant Infectious Disease, 12(1):1-10.

Schorn, R; Höhne, M; Meerbach, A; Bossart, W; Wüthrich, R P; Schreier, E; Müller, N J; Fehr, T (2010). Chronic norovirus infection after kidney transplantation: molecular evidence for immune-driven viral evolution. Clinical Infectious Diseases, 51(3):307-314.

Mueller, N J; Weisser, M; Fehr, T; Wüthrich, R P; Müllhaupt, B; Lehmann, R; Imhof, A; Aubert, J D; Genoni, M; Kunz, R; Weber, M; Steiger, J (2010). Donor-derived aspergillosis from use of a solid organ recipient as a multiorgan donor. Transplant Infectious Disease, 12(1):54-59.

Riethmüller, S; Ferrari-Lacraz, S; Müller, M K; Raptis, D A; Hadaya, K; Rüsi, B; Laube, G; Schneiter, G; Fehr, T; Villard, J (2010). Donor-specific antibody levels and three generations of crossmatches to predict antibody-mediated rejection in kidney transplantation. Transplantation, 90(2):160-167.

Reser, D; Tavakoli, R; Fehr, T (2010). Erste schweizerische zweizeitige Herz-Nieren-Transplantation mit Organen desselben Donors. Swiss Medical Forum, 10(39):670-672.

Cusini, A; Günthard, H F; Stussi, G; Schwarz, U; Fehr, T; Grueter, E; Meerbach, A; Bossart, W; Schaer, D J; Rudiger, A (2010). Hemophagocytic syndrome caused by primary herpes simplex virus 1 infection: report of a first case. Infection, 38(5):423-426.

Fritschi, B C; Trachsler, J; Varga, Z; Binet, I; Fehr, T (2010). Iatrogenic nephrocalcinosis with acute renal failure: an underestimated complication after parathyroidectomy? NDT Plus, 3(6):551-554.

Tian, Y; Chen, J; Gaspert, A; Segerer, S; Clavien, P A; Wüthrich, R P; Fehr, T (2010). Kidney transplantation in mice using left and right kidney grafts. Journal of Surgical Research, 163(2):e91-e97.

Oettl, T; Zuliani, E; Gaspert, A; Hopfer, H; Dickenmann, M; Fehr, T (2010). Late steroid withdrawal after ABO blood group-incompatible living donor kidney transplantation: high rate of mild cellular rejection. Transplantation, 89(6):702-706.

Starke, A; Lindenmeyer, M T; Segerer, S; Neusser, M A; Rüsi, B; Schmid, D M; Cohen, C D; Wüthrich, R P; Fehr, T; Waeckerle-Men, Y (2010). Renal tubular PD-L1 (CD274) suppresses alloreactive human T-cell responses. Kidney International, 78(1):38-47.

Gaspert, A; Lüthi, B; Mueller, N J; Bossart, W; Heim, A; Wüthrich, R P; Fehr, T (2009). Subacute allograft failure with dysuria and hematuria in a kidney transplant recipient. American Journal of Kidney Diseases, 54(1):154-158.

Grimmelt, A C; Cohen, C D; Fehr, T; Serra, A L; Wüthrich, R P (2009). Safety and tolerability of ferric carboxymaltose (FCM) for treatment of iron deficiency in patients with chronic kidney disease and in kidney transplant recipients. Clinical Nephrology, 71(2):125-129.

Valli, P V; Puga Yung, G; Fehr, T; Schulz-Huotari, C; Kaup, N; Güngör, T; Ambühl, P; Weber, M; Schanz, U; Seebach, J D; Stüssi, G (2009). Changes of circulating antibody levels induced by ABO antibody adsorption for ABO-incompatible kidney transplantation. American Journal of Transplantation, 9(5):1072-1080.

Bonani, M; Fehr, T (2009). Chronische Niereninsuffizienz in der Hausarztpraxis. Praxis, 98(15):823-832.

Fehr, T; Rüsi, B; Fischer, A; Hopfer, H; Wüthrich, R P; Gaspert, A (2009). Rituximab and intravenous immunoglobulin treatment of chronic antibody-mediated kidney allograft rejection. Transplantation, 87(12):1837-1841.

Fehr, T; Sykes, M (2008). Clinical experience with mixed chimerism to induce transplantation tolerance. Transplant International, 21(12):1118-1135.

Henz, S; Maeder, M T; Huber, S; Schmid, M; Loher, M; Fehr, T (2008). Influence of drugs and comorbidity on serum potassium in 15 000 consecutive hospital admissions. Nephrology, Dialysis, Transplantation, 23(12):3939-3945.

Elke, B; Gaspert, A; Fehr, T (2008). Akute/subakute Niereninsuffizienz: Leitsymptome: Akuter Anstieg des Serumkreatinins und/oder Oligurie/Anurie. Praxis, 97(20):1057-1066.

Elke, B; Ludin, S; Fehr, T (2008). Makro- und Mikrohämaturie beim Erwachsenen. Praxis, 97:755-761.

Trachsler, J; Gaspert, A; Previsdomini, M; Wüthrich, R P; Fehr, T (2008). Massive uric acid nephrolithiasis with progressive renal failure due to spontaneous tumour lysis syndrome. NDT Plus, 5(1):307-309.

Fehr, T; Wüthrich, R P (2008). Monoklonale Antikörpertherapie bei der Organtransplantation. Swiss Medical Forum, 8(11):204-209.

Wüthrich, R P; Fehr, T (2008). Probleme nach Nierentransplantation: Ein Drittel der Todesfälle geht auf kardiovaskuläre Komplikationen zurück. Cardiovasc, 7:8-12.

Elke, B; Ludin, S; Fehr, T (2008). Proteinurie. Praxis, 97(15):811-818.

This list was generated on Wed Jul 26 01:00:59 2017 CEST.